We are proud to announce that due to our remarkable growth in biostatistics and statistical programming, we were recently moving to a new office location. We will continue to offer the same costumer-friendly service from our new address at Aschauer Str. 26b in Munich,...

Staburo participated in the APF meeting on 24 November 2017 in Freiburg. This year, the APF was hosted by Roche. Speakers from pharmaceutical industry, academia and regulatory agencies discussed important topics on estimands, safety and Health Technlogy Assessment....

Big steps for Staburo in 2017 Last year was very successful for our company. Our major milestones were: Strategy workshop with Mission & Vision for 2022 Further internationalization with additional US, EU and UK projects New big pharma & new biomarker project...

The 2nd Annual Biosimilars Forum was hosted in Budapest in October 2017. Clinicians, statisticians and regulatory representatives from around the world gathered here, to share with each other their perspectives on this hot topic of research, in lectures and informal...

Staburo took part in the WiMa17 Congress at the University Ulm. The WiMa Congress is a networking forum for companies and students from a mathematics, finance, IT, and biometry background. At the WiMa Congress, companies have the opportunity to present themselves, get...

Imagine we had a cure for cancer, but patients don't receive it? This sounds very disturbing, but it can happen to the most effective drugs, if Crossover Correction is not taken into account. To share our profound expertise on this topic, our Head of Biostatistics Dr....

Staburo will take part in this year’s BVMA symposium on 24 November 2017, at the Westin Grand Hotel München, here in Munich. The BVMA represents the interests of its German CRO members. The BVMA members maintain a lively exchange of information on all topics that are...

Staburo's Head of Biostatistics Dr. Hannes Buchner took part in the first Roche Future X Healthcare 2017 event in Munich. The topic was „Making Data Meaningful – from Science to Patients“, a motto that could easily fit to our daily work at Staburo. The agenda started...

Staburo's Managing Director Roland Stieger joined the BIO-Europe for the third time and enjoyed the good organization and networking opportunities of this partnering conference. The event started with a great panel discussion, with relevance for Staburo "The evolving...